Evidence map›Paper›PMID 32378408›Full record

ArticleJournal of agricultural and food chemistry2020

Mechanistic Differences in the Inhibition of NF-κB by Turmeric and Its Curcuminoid Constituents.

Rebecca L Edwards, Paula B Luis, Fumie Nakashima, Andrew G Kunihiro, Sai-Han Presley, Janet L Funk, Claus Schneider

Open access · greenAbstract read
In one paragraph

Article in Journal of agricultural and food chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 39 citations in OpenAlex.

  1. Chemical constituents in the rhizome of Curcuma longa and the pharmacological importance of curcumin hybrids.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Rebecca L EdwardsDepartment of Pharmacology, Division of Clinical Pharmacology, and Vanderbilt Institute of Chemical Biology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States.
Paula B LuisDepartment of Pharmacology, Division of Clinical Pharmacology, and Vanderbilt Institute of Chemical Biology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States.
Fumie NakashimaDepartment of Pharmacology, Division of Clinical Pharmacology, and Vanderbilt Institute of Chemical Biology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States.
Andrew G KunihiroDepartment of Nutritional Sciences, University of Arizona, Tucson, Arizona 85719, United States.
Sai-Han PresleyDepartment of Pharmacology, Division of Clinical Pharmacology, and Vanderbilt Institute of Chemical Biology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States.
Janet L FunkDepartment of Nutritional Sciences, University of Arizona, Tucson, Arizona 85719, United States.
Claus SchneiderDepartment of Pharmacology, Division of Clinical Pharmacology, and Vanderbilt Institute of Chemical Biology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States.ORCID http://orcid.org/0000-0003-4215-967X
Vanderbilt University · USUniversity of Arizona · US

Funding

Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
Oxidative activation of the dietary cancer chemopreventive agent curcuminR01AT006896 · NCCIH · VANDERBILT UNIVERSITY · PI SCHNEIDER, CLAUS · 2013 to 2017
$2.2M
Exploiting the Tumor Microenvironment to Block Breast Cancer Bone MetastasisR01CA174926 · NCI · UNIVERSITY OF ARIZONA · PI FUNK, JANET L · 2014 to 2018
$1.6M
Curcuma longa L. in Rheumatoid Arthritis (CLaRA): Clinical Planning StudyR34AT007837 · NCCIH · UNIVERSITY OF ARIZONA · PI FUNK, JANET L · 2013 to 2015
$737k
Bone-specific deglucuronidation of turmeric-derived curcuminoids for the treatment of osteolytic diseaseF31AT009938 · NCCIH · UNIVERSITY OF ARIZONA · PI KUNIHIRO, ANDREW GEORGE KENRO · 2018 to 2019
$61k
NCCIH NIH HHS F31 AT009938NCCIH NIH HHS R01 AT006896NCCIH NIH HHS R34 AT007837NCI NIH HHS R01 CA174926NIDDK NIH HHS P30 DK058404
6 · The paper itself

Abstract

Turmeric extract, a mixture of curcumin and its demethoxy (DMC) and bisdemethoxy (BDMC) isomers, is used as an anti-inflammatory preparation in traditional Asian medicine. Curcumin is considered to be the major bioactive compound in turmeric but less is known about the relative anti-inflammatory potency and mechanism of the other components, their mixture, or the reduced in vivo metabolites. We quantified inhibition of the NF-κB pathway in cells, adduction to a peptide mimicking IκB kinase β, and the role of cellular glutathione as a scavenger of electrophilic curcuminoid oxidation products, suggested to be the active metabolites. Turmeric extracts (IC

Indexed as

AnimalsCell LineCurcumaCurcuminDiarylheptanoidsHumansKineticsNF-kappa BOxidation-ReductionPlant ExtractsCurcuminDiarylheptanoidsNF-kappa BPlant Extractsturmeric extractanti-inflammatorycurcumindegradationpolyphenolturmeric

Identifiers

PMID32378408
PMCPMC8406555
OpenAlexW3022732743

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.